l-Fucose是一种候选单糖神经调节剂,可以缓解阿尔茨海默氏症的突触缺陷
Jacopo Di Lucente1,2, Jennyfer Tena3, Yuanyuan Bai3
1Department of Pathology and MIND Institute, University of California Davis Medical Center, 2805 50th Street, Sacramento, CA 95817, USA.
Science advances
|November 7, 2025
概括
自由的l-糖通过促进神经传递和突触可塑性来增强大脑功能. 补充表明阿尔茨海默氏症的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 代谢途径 代谢途径
- 葡萄糖生物学 葡萄糖生物学
背景情况:
- 可化会影响神经元和微质功能.
- 未结合的自由l-糖在大脑功能中的作用仍然不清楚.
- l-Fucose通过福柯酶 (FCSK) 救援途径进行代谢.
研究的目的:
- 为了研究自由l-糖对大脑功能的影响.
- 探索l-糖在阿尔茨海默氏症 (AD) 的治疗潜力.
主要方法:
- 利用小鼠海马片来研究神经传递和长期潜能 (LTP).
- 研究了FCSK救援途径在l-糖代谢中的作用.
- 在人类AD和5xFAD小鼠模型中检查了l-糖信号.
- 对5xFAD小鼠进行了食l-糖补充剂.
主要成果:
- l-Fucose在小鼠海马中增强了刺激性神经传递和LTP.
- 这些效应取决于FCSK介导的新陈代谢,表明代谢信号作用.
- 阿尔茨海默病的模型表现出糖低代谢和受损的l-糖信号传递.
- 在5xFAD小鼠中,外源性l-糖纠正了LTP缺陷.
- 在5xFAD小鼠中,食补充l-糖改善了突触和行为缺陷.
结论:
- 自由的l-糖具有未知的神经调节功能.
- 由FCSK驱动的救援通路对于l-fucose对突触功能的影响至关重要.
- 糖代谢功能障碍与阿尔茨海默病有关.
- l-Fucose在阿尔茨海默病中显示出显著的治疗潜力.
更多相关视频
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
9.7K
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
1.1K
相关概念视频
01:22Alzheimer's Disease: Treatment
782
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
782
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:23Role of Neurotransmitters in Memory
2.4K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.4K